MAPT and COVID-19: Interestingly, a small neuropathology study showed abnormal accumulation of hyperphosphorylated Tau protein, absent concomitant with changes in cerebral amyloidosis 4–13 months after recovery from acute COVID-19 in three patients who died after recovering from SARS-CoV-2 infection.18